{"date":"2025-02-04","count":9,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6932-2025-02-04-2153-tulf6t","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2025-02-04","time":"21:53:43","subject":"公告本公司董事會決議召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2025-02-04 21:53，「公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2025-02-04-2152-ej4sue","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2025-02-04","time":"21:52:54","subject":"公告本公司董事會決議通過設置永續發展委員會暨委任永續發展委員會之委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2025-02-04 21:52，「公告本公司董事會決議通過設置永續發展委員會暨委任永續發展委員會之委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2025-02-04-2152-1v1nr2p","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2025-02-04","time":"21:52:22","subject":"公告本公司新任薪酬委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2025-02-04 21:52，「公告本公司新任薪酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2025-02-04-2152-1t11r5w","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2025-02-04","time":"21:52:01","subject":"公告本公司董事會決議通過發行限制員工權利新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2025-02-04 21:52，「公告本公司董事會決議通過發行限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2025-02-04-2151-1v08jg1","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2025-02-04","time":"21:51:13","subject":"公告本公司董事會決議辦理私募發行普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2025-02-04 21:51，「公告本公司董事會決議辦理私募發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-02-04-2005-17uvhgq","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-02-04","time":"20:05:39","subject":"更正本公司初次申請上市、櫃(興櫃)或TDR用之公開說明書部分內容","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-02-04 20:05，「更正本公司初次申請上市、櫃(興櫃)或TDR用之公開說明書部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-02-04-1820-eg96ov","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-02-04","time":"18:20:20","subject":"本公司美國子公司PhiBio Therapeutics Inc.自體細胞新藥TRK-001取得台灣衛生福利部原則同意進行預防活體腎臟移植受贈者排斥反應之二期人體臨床試驗","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-02-04 18:20，「本公司美國子公司PhiBio Therapeutics Inc.自體細胞新藥TRK-001取得台灣衛生福利部原則同意進行」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-02-04-1753-1q8z05x","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-02-04","time":"17:53:40","subject":"公告本公司董事會決議召開114年第一次股東臨時會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-02-04 17:53，「公告本公司董事會決議召開114年第一次股東臨時會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-02-04-1658-p67uuk","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-02-04","time":"16:58:58","subject":"公告本公司內部稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-02-04 16:58，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}